News EU probes Aspen price gouging allegations Aspen pulled drugs from some countries that rejected price hikes, says EU.
News GSK sells anaesthetics portfolio to Aspen Companies also end collaboration in sub-Saharan Africa.
News BioMarin ends year with $4.8bn play for Amicus BioMarin takes a leap towards its $4bn revenue target with a $4.8bn deal to acquire Amicus, which has two rare disease therapies on the market.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
